USPTO serial 87346999
Serial No. 87346999
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 30, 2021
- Examiner
- AWRICH, ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 87346999?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
Owner
Pharmaceutical Research and Manufacturers of America
Washington, DC, US
Other trademarks owned by Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America
Washington, DC, US
Other trademarks owned by Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America
Washington, DC, US
Other trademarks owned by Pharmaceutical Research and Manufacturers of America
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Brett Heavner
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue NWWashington, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic downloadable publications in the nature of fact sheets, reports, and infographics regarding biopharmaceuticals and the biopharmaceutical industry | ACTIVE | — |
| 035 | Association services, namely, promoting the interests of research-based prescription drug manufacturers | ACTIVE | — |
| 041 | Providing a website featuring non-downloadable publications in the nature of testimonials, infographics, fact sheets, reports, articles, and videos regarding biopharmaceuticals and the biopharmaceutical industry | ACTIVE | — |
| 042 | Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmaceutical Research and Manufacturers of America
- Other trademarks owned by Pharmaceutical Research and Manufacturers of America
- Other trademarks owned by Pharmaceutical Research and Manufacturers of America
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 30, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 7, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 7, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 7, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 7, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 23, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 22, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 22, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 19, 2021 | IUAF | USE AMENDMENT FILED | — |
| Feb 19, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 9, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 9, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 22, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 13, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 11, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 11, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 20, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 16, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 16, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 16, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 7, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 5, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 5, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 5, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 13, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 11, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 11, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 11, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 20, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 26, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 26, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 15, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 23, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 23, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 18, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2017 | NWAP | NEW APPLICATION ENTERED | — |